Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients.

Oncoimmunology · 2023 · PMC10503454 · PMID 37720688

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Only the NCM count was significantly higher in NP patients than in P patients at T1, whereas, an increasing trend was detected for the other two monocytic subsets in NP patients at T0 (Supplementary Figure S3c).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.